OA09387A - "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues". - Google Patents

"Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues".

Info

Publication number
OA09387A
OA09387A OA60055A OA60055A OA09387A OA 09387 A OA09387 A OA 09387A OA 60055 A OA60055 A OA 60055A OA 60055 A OA60055 A OA 60055A OA 09387 A OA09387 A OA 09387A
Authority
OA
OAPI
Prior art keywords
compositions
sustained
preparation
release
release compositions
Prior art date
Application number
OA60055A
Other languages
English (en)
Inventor
Ruiz Jean-Marc
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of OA09387A publication Critical patent/OA09387A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
OA60055A 1990-08-01 1991-08-01 "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues". OA09387A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
OA09387A true OA09387A (fr) 1992-09-15

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60055A OA09387A (fr) 1990-08-01 1991-08-01 "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues".

Country Status (30)

Country Link
US (1) US5213812A (fr)
JP (1) JP2818704B2 (fr)
KR (1) KR920003962A (fr)
AT (1) AT396425B (fr)
AU (2) AU649696B2 (fr)
BE (1) BE1004772A3 (fr)
CA (1) CA2048270C (fr)
CH (1) CH682715A5 (fr)
DE (1) DE4125542A1 (fr)
DK (1) DK175756B1 (fr)
ES (1) ES2046083B1 (fr)
FI (1) FI104149B (fr)
FR (1) FR2665360B1 (fr)
GB (1) GB9016885D0 (fr)
GR (1) GR1001512B (fr)
HK (1) HK33294A (fr)
IE (1) IE65124B1 (fr)
IN (1) IN178446B (fr)
IT (1) IT1251788B (fr)
LU (1) LU87982A1 (fr)
MA (1) MA22245A1 (fr)
MY (1) MY107500A (fr)
NL (1) NL194637C (fr)
NO (1) NO300158B1 (fr)
NZ (1) NZ238981A (fr)
OA (1) OA09387A (fr)
PT (1) PT98497B (fr)
SE (1) SE505734C2 (fr)
TN (1) TNSN91067A1 (fr)
ZA (1) ZA915565B (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
WO1995022963A1 (fr) * 1994-02-28 1995-08-31 Medinova Medical Consulting Gmbh Systeme de ciblage d'un medicament, procede de preparation et utilisation de ce medicament
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
EP0930874A2 (fr) * 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. Procede de production d'une microparticule
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
WO1999052708A1 (fr) 1998-04-13 1999-10-21 Luminex Corporation Marquage liquide a l'aide de microparticules fluorescentes
ATE303795T1 (de) * 1998-12-16 2005-09-15 Aventis Pharma Inc In biologisch abbaubare polymere eingekapselter serotoninrezeptor-antagonist und deren herstellungsverfahren
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
ATE430558T1 (de) 2000-10-27 2009-05-15 Baxter Healthcare Sa Herstellung von mikrokügelchen
US20030064033A1 (en) * 2001-08-16 2003-04-03 Brown Larry R. Propellant-based microparticle formulations
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
BRPI0412735A (pt) * 2003-07-18 2006-09-26 Baxter Int métodos para a fabricação, uso e composição de partìculas esféricas pequenas preparadas mediante a separação de fase controlada
JP2007508240A (ja) * 2003-07-22 2007-04-05 バクスター・インターナショナル・インコーポレイテッド 低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
MXPA06012992A (es) * 2004-05-12 2007-02-12 Baxter Int Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente.
CA2566199C (fr) * 2004-05-12 2013-10-22 Baxter International Inc. Administration de microspheres d'oligonucleotides antisens pour induire une tolerance de cellules dendritiques pour le traitement du diabete de type 1 insulino-dependant
EP1765294B1 (fr) 2004-05-12 2008-09-24 Baxter International Inc. Production et administration de microsphères d'acide nucléique
AU2005271781A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
AU2005271782A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for controlled release of drugs
JP2008528443A (ja) * 2004-10-29 2008-07-31 アドヒーシブズ・リサーチ・インコーポレイテッド セキュリティ・アイデンティフィケーションのための微視的なタグ付けシステム
EP1885335A1 (fr) * 2005-04-27 2008-02-13 BAXTER INTERNATIONAL INC. (a Delaware corporation) Microparticules a surface modifiee et procedes de formation et d'utilisation associes
EP1928814A2 (fr) * 2005-08-23 2008-06-11 Altairnano, Inc Composition d'anatase-tio2 dopee au phosphore hautement catalytique et methodes de fabrication connexes
WO2007103820A1 (fr) * 2006-03-02 2007-09-13 Altairnano, Inc. Oxyde de fer dopé à l'indium nanostructuré
WO2007103824A1 (fr) * 2006-03-02 2007-09-13 Altairnano, Inc. Oxydes métalliques nanostructurés
US20080038482A1 (en) * 2006-03-02 2008-02-14 Fred Ratel Method for Low Temperature Production of Nano-Structured Iron Oxide Coatings
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
CN101500616A (zh) 2006-08-04 2009-08-05 巴克斯特国际公司 预防和/或逆转新发作自身免疫糖尿病的基于微球的组合物
WO2008060786A2 (fr) * 2006-10-06 2008-05-22 Baxter International Inc. Microcapsules contenant des microparticules modifiées en surface et leurs procédés de formation et d'utilisation
AU2007306936B2 (en) 2006-10-12 2014-02-06 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
CN101686939B (zh) * 2007-04-17 2013-03-27 巴克斯特国际公司 用于肺部投送的核酸微粒
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
ES2686708T3 (es) 2008-04-18 2018-10-19 Baxter International Inc. Composición basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nueva aparición
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
WO2010037021A2 (fr) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Filière et procédé de filage d’une fibre
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
US20100291384A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
BRPI1012036A2 (pt) 2009-05-27 2017-10-10 Selecta Biosciences Inc nanocarreadores que possuem componentes com diferentes taxas de liberação
US20110076771A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
CA2798739A1 (fr) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Compositions de nanovecteurs comportant un adjuvant decouple
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
US11311610B2 (en) 2010-11-01 2022-04-26 University Of Technology Sydney Immune-modulating agents and uses therefor
KR20140050698A (ko) 2011-07-29 2014-04-29 셀렉타 바이오사이언시즈, 인크. 체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
US10695406B2 (en) 2014-05-27 2020-06-30 The University Of Queensland Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (fr) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
EP0366058A3 (fr) * 1988-10-27 1991-03-20 Abbott Laboratories Dispositif de délivrance à libération contrôlée, procédé de préparation du dispositif et méthode d'utilisation du dispositif

Also Published As

Publication number Publication date
PT98497B (pt) 1997-10-31
MY107500A (en) 1995-12-30
ATA152591A (de) 1993-01-15
SE9102249D0 (sv) 1991-07-26
NL9101306A (nl) 1992-03-02
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
DK175756B1 (da) 2005-02-14
IT1251788B (it) 1995-05-26
GR1001512B (el) 1994-02-28
GR910100330A (en) 1992-08-31
AU649696B2 (en) 1994-06-02
SE9102249L (sv) 1992-02-02
FI913646L (fi) 1992-02-02
CA2048270A1 (fr) 1992-02-02
FR2665360A1 (fr) 1992-02-07
DE4125542A1 (de) 1992-02-06
US5213812A (en) 1993-05-25
GB9016885D0 (en) 1990-09-12
IN178446B (fr) 1997-05-03
DK141891A (da) 1992-02-02
ES2046083B1 (es) 1994-08-01
JPH05178740A (ja) 1993-07-20
LU87982A1 (fr) 1992-04-15
NO300158B1 (no) 1997-04-21
DK141891D0 (da) 1991-07-31
FI913646A0 (fi) 1991-07-31
ES2046083A1 (es) 1994-01-16
ZA915565B (en) 1992-04-29
PT98497A (pt) 1992-06-30
JP2818704B2 (ja) 1998-10-30
ITMI911953A1 (it) 1993-01-15
ITMI911953A0 (it) 1991-07-15
AU5939394A (en) 1994-06-02
NL194637C (nl) 2002-10-04
FI104149B1 (fi) 1999-11-30
IE912700A1 (en) 1992-02-12
NZ238981A (en) 1992-11-25
HK33294A (en) 1994-04-22
KR920003962A (ko) 1992-03-27
AU8146691A (en) 1992-02-06
IE65124B1 (en) 1995-10-04
SE505734C2 (sv) 1997-10-06
TNSN91067A1 (fr) 1992-10-25
NO912986D0 (no) 1991-07-31
FR2665360B1 (fr) 1995-02-10
MA22245A1 (fr) 1992-04-01
CA2048270C (fr) 1997-02-25
FI104149B (fi) 1999-11-30
AU666808B2 (en) 1996-02-22
BE1004772A3 (fr) 1993-01-26
AT396425B (de) 1993-09-27
CH682715A5 (fr) 1993-11-15

Similar Documents

Publication Publication Date Title
OA09387A (fr) "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues".
MA22668A1 (fr) Procede de preparation d'oxamides .
FR2707087B1 (fr) Nouveau procédé de préparation de l'ergothionéine.
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
EP0657438A3 (fr) Procédé pour la préparation d'alkylesulfinylbenzamides et de 1,2-benzoisothiazol-3-ones.
FR2720070B1 (fr) Procédé de préparation d'alkylpolysiloxanes pontés et alkylpolysiloxanes pontés.
EP0685491A3 (fr) Procédé de production d'une préparation d'albumine.
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
EP0729938A3 (fr) Procédé pour la préparation d'aryle-alkyle-hydropéroxydes
FR2594839B1 (fr) Procede de fractionnement d'asphaltes solides
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
FR2712492B1 (fr) Compositions cosmétiques à base d'eaux thermales et leur procédé de préparation.
FR2715656B1 (fr) Procédé de préparation d'anhydride citraconique.
FR2695645B1 (fr) Procédé de préparation de polyaminoborazines.
FR2644161B1 (fr) Procede de preparation d'amides n-arylsubstitues
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi
FI880282L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi
FR2694933B1 (fr) Procédé de préparation d'isocyanates d'acyle.
FR2705672B1 (fr) Procédé de préparation de nitrophénols.
FR2714385B1 (fr) Copolymère d'acide phosphonique-carboxylique et procédé de préparation de ce copolymère.
FR2700538B1 (fr) Procédé de préparation de 2-méthyl-3-aminobenzotrifluorure.
FR2712594B1 (fr) Procédé de préparation de l'oenotheine B à partir d'Epilobium Parviflorum.
FR2668707B1 (fr) Procede de preparation d'une composition pharmaceutique.
FR2499368B1 (fr) Procede de preparation de compositions a base d'olives et compositions obtenues
FR2616441B1 (fr) Procede de preparation d'additifs surbases et compositions renfermant lesdits additifs